
News|Videos|September 1, 2020
Diana Isaacs, PharmD: An Overview of Insulin Affordability in 2020
Insulin affordability is an ongoing discussion topic for patients with diabetes and their care providers. The already difficult issue has been further compounded by the ongoing COVID-19 pandemic.
Advertisement
In the following interview, Diana Isaacs, PharmD, a clinical pharmacist and diabetes care and education specialist at the Cleveland Clinic, discusses the affordability of insulin and how the ability of patients to afford their medications has been impacted by the pandemic.
A leader in her field, Isaacs offers perspective on topics from how to approach these delicate conversations with patients to the best resources for patients who may be struggling to afford their insulin.
Advertisement
Advertisement
Advertisement
Trending on Patient Care Online
1
ACOG Releases New Guidance on HIV Screening and Prevention
2
2026 Dyslipidemia Guideline Expands Statin Eligibility to 21.5 Million More US Adults
3
From Amyloid Clearance to Daytime Function: Why Sleep Quality Matters for Brain Health
4
FDA Approves First Oral PCSK9 Inhibitor to Reduce LDL-C in Adults With Hypercholesterolemia
5





























































































































































